Safer Compounding for Patients

This page ran 181 paid political ads on Facebook and Instagram between 5 June 2026 and 13 August 2026. Meta reports $5–22.9K of spend, which makes it the 3,410th largest advertiser of the 24,034 pages in our data. Advertiser type: Unidentified. Most of its spend took no side. Race: No specific race. Paid for by Safer Compounding for Patients, a project of Novo Nordisk, Inc..

Data from the Meta Ad Library, pulled 4 November 2026. Election on 3 November 2026. · Every ad of this page in Meta’s Ad Library ↗

181

ads

$14K

reported spend, range $5–22.9K

0.0%

of spend on federal races

$50

median spend per ad

Spend by week the ad started

1 Jun

6 Jul

3 Aug

7 Sep

5 Oct

Spend still counting

2 Nov

Tone

Promotional

50%

Informational

50%

Share of the 181 ads with text that our model classified. Attack ads name an opponent.

Topics

Health

100%

Spend by race: No specific race 100%.

Spend by ad language: English 100%.

The costliest ads

The highest-spend ad of each distinct text, as it ran.

California has an opportunity to close dangerous gaps and set a higher standard for patient safety. AB 1990 helps protect patients from the use of poor-quality active pharmaceutical ingredients (APIs) in compounded weight-loss drugs. Stronger safeguards, greater transparency, and higher standards will help ensure Californians are better protected from risks of potentially unsafe products. California has a duty to protect patients. Yes on AB 1990.
10 August 2026 · Safer Compounding for Patients · $400 – $499 · 70K+ impressions · Informational · Ad Library
Patients rely on the U.S. drug approval system because it ensures medications are rigorously tested for safety and effectiveness before they are sold. While compounding plays an important role for patients with unique medical needs, gaps in oversight are allowing unsafe products to enter the market, putting patients at unnecessary risk. Patients deserve better. Yes on AB 1990.
5 June 2026 · Safer Compounding for Patients · $400 – $499 · 70K+ impressions · Promotional · Ad Library
California has an opportunity to close dangerous gaps and set a higher standard for patient safety. AB 1990 helps protect patients from the use of poor-quality active pharmaceutical ingredients (APIs) in compounded weight-loss drugs. Stronger safeguards, greater transparency, and higher standards will help ensure Californians are better protected from risks of unsafe drugs. California has a duty to protect patients. Yes on AB 1990.
5 June 2026 · Safer Compounding for Patients · $400 – $499 · 35K+ impressions · Informational · Ad Library
Patients rely on the U.S. drug approval system because it ensures medications are rigorously tested for safety and effectiveness before they are sold. While compounding plays an important role for patients with unique medical needs, gaps in oversight are allowing potentially unsafe products to enter the market, putting patients at unnecessary risk. Patients deserve better. Yes on AB 1990.
11 August 2026 · Safer Compounding for Patients · $200 – $299 · 4K+ impressions · Promotional · Ad Library

Figures cover domestic political ads paid in dollars, from 4 May 2026. Spend is the sum of Meta’s range midpoints; impressions above one million are reported as “1M+”, so impression figures are floors. Each ad counts in the week its delivery started, with its lifetime spend at our last pull; ads still running before the vote are counted as of 31 October 2026.

Back to the United States report, both parties and every candidate or every advertiser.